MAFLD-Epidemiology, Natural History, Outcomes and Prevention

Aimun Raees, Muhammad Kamran and Wasim Jafri

European Journal of Medical and Health Sciences, 2021, vol. 3, issue 4, 12-17

Abstract: Scientists have recently modified the term Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in an attempt to improve the understanding and overall outcomes of the disease. The leaping prevalence and formidable mortality rate of fatty liver disease throughout the world is quite worrisome. Due to the lack of appropriate knowledge of the natural history of disease, suitable pharmacotherapy could never be devised. Thus, the management solely relies on patients’ earnest co-operation with fierce lifestyle changes such as exercise, weight loss and dietary modifications. In this era, it is essential to come up with strategies to curtail the underlying risk factors in order to prevent the rapid progression of MAFLD. In this review, we will discuss the epidemiology of NAFLD and the newly found evidence on.

Keywords: Epidemiology; MAFLD; NAFLD; Natural history; Prevention (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/40941 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/40941/9310 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:3:y:2021:i:4:id:40941

DOI: 10.24018/ejmed.2021.3.4.941

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().